Shift from ustekinumab originator to biosimilars in Denmark.

Saved in:
Bibliographic Details
Title: Shift from ustekinumab originator to biosimilars in Denmark.
Authors: Loft N; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark., Nguyen TT; Unit of Social Medicine, Frederiksberg Hospital, Frederiksberg, Denmark., Zachariae C; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Kaur-Knudsen D; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark., Andersson NW; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark., Bartels D; Amgros, Copenhagen, Denmark., Seidelin J; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Digestive Diseases, Transplantation and General Surgery, Rigshospitalet, Copenhagen, Denmark., Skov L; Department of Dermatology and Allergy, Copenhagen University Hospital-Herlev and Gentofte, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Source: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2026 Jun; Vol. 40 (6), pp. e476-e478. Date of Electronic Publication: 2025 Nov 26.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1468-3083
DOI:10.1111/jdv.70224